 | • レポートコード：B-GIR09D2772 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ヘルペス後神経痛薬の世界市場について調べ、まとめました。種類別セグメントは、抗けいれん薬、抗うつ薬、オピオイド、その他等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。ヘルペス後神経痛薬の世界市場概観、メーカー動向、メーカー別ヘルペス後神経痛薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ヘルペス後神経痛薬の市場概観 ・ヘルペス後神経痛薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ヘルペス後神経痛薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・ヘルペス後神経痛薬の世界市場規模 ・ヘルペス後神経痛薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・ヘルペス後神経痛薬のアメリカ市場規模推移 ・ヘルペス後神経痛薬のカナダ市場規模推移 ・ヘルペス後神経痛薬のメキシコ市場規模推移 ・ヘルペス後神経痛薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ヘルペス後神経痛薬のドイツ市場規模推移 ・ヘルペス後神経痛薬のイギリス市場規模推移 ・ヘルペス後神経痛薬のロシア市場規模推移 ・ヘルペス後神経痛薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ヘルペス後神経痛薬の日本市場規模推移 ・ヘルペス後神経痛薬の中国市場規模推移 ・ヘルペス後神経痛薬の韓国市場規模推移 ・ヘルペス後神経痛薬のインド市場規模推移 ・ヘルペス後神経痛薬の東南アジア市場規模推移 ・ヘルペス後神経痛薬の南米市場分析（ブラジル、アルゼンチン等） ・ヘルペス後神経痛薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ヘルペス後神経痛薬の種類別分析/販売量、売上、市場シェア（抗けいれん薬、抗うつ薬、オピオイド、その他） ・ヘルペス後神経痛薬の用途別分析/市場規模（病院薬局、オンライン薬局、小売薬局） ・ヘルペス後神経痛薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ヘルペス後神経痛薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Scope of the Report:
The worldwide market for Post Herpetic Neuralgia Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Post Herpetic Neuralgia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Depomed
Pfizer
Daiichi Sankyo
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anticonvulsants
Antidepressants
Opioids
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Post Herpetic Neuralgia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Post Herpetic Neuralgia Drugs, with price, sales, revenue and global market share of Post Herpetic Neuralgia Drugs in 2017 and 2018.
Chapter 3, the Post Herpetic Neuralgia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Post Herpetic Neuralgia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Post Herpetic Neuralgia Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Post Herpetic Neuralgia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Post Herpetic Neuralgia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Anticonvulsants
1.2.2 Antidepressants
1.2.3 Opioids
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Depomed
2.1.1 Business Overview
2.1.2 Post Herpetic Neuralgia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Depomed Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Post Herpetic Neuralgia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Daiichi Sankyo
2.3.1 Business Overview
2.3.2 Post Herpetic Neuralgia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Post Herpetic Neuralgia Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Post Herpetic Neuralgia Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Post Herpetic Neuralgia Drugs Market Analysis by Regions
4.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
4.5 South America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
5 North America Post Herpetic Neuralgia Drugs by Country
5.1 North America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
6 Europe Post Herpetic Neuralgia Drugs by Country
6.1 Europe Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
6.3 UK Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
6.4 France Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Post Herpetic Neuralgia Drugs by Country
7.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
7.5 India Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
8 South America Post Herpetic Neuralgia Drugs by Country
8.1 South America Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Post Herpetic Neuralgia Drugs by Countries
9.1 Middle East and Africa Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Post Herpetic Neuralgia Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
10 Global Post Herpetic Neuralgia Drugs Market Segment by Type
10.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Post Herpetic Neuralgia Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Post Herpetic Neuralgia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Anticonvulsants Sales Growth and Price
10.2.1 Global Anticonvulsants Sales Growth (2014-2019)
10.2.2 Global Anticonvulsants Price (2014-2019)
10.3 Antidepressants Sales Growth and Price
10.3.1 Global Antidepressants Sales Growth (2014-2019)
10.3.2 Global Antidepressants Price (2014-2019)
10.4 Opioids Sales Growth and Price
10.4.1 Global Opioids Sales Growth (2014-2019)
10.4.2 Global Opioids Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Post Herpetic Neuralgia Drugs Market Segment by Application
11.1 Global Post Herpetic Neuralgia Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Online Pharmacies Sales Growth (2014-2019)
11.4 Retail Pharmacies Sales Growth (2014-2019)
12 Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.1 Global Post Herpetic Neuralgia Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Post Herpetic Neuralgia Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.2.2 Europe Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.2.4 South America Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
12.3 Post Herpetic Neuralgia Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Type (2019-2024)
12.4 Post Herpetic Neuralgia Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Post Herpetic Neuralgia Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Post Herpetic Neuralgia Drugs Picture
Table Product Specifications of Post Herpetic Neuralgia Drugs
Figure Global Sales Market Share of Post Herpetic Neuralgia Drugs by Types in 2018
Table Post Herpetic Neuralgia Drugs Types for Major Manufacturers
Figure Anticonvulsants Picture
Figure Antidepressants Picture
Figure Opioids Picture
Figure Others Picture
Figure Post Herpetic Neuralgia Drugs Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure Retail Pharmacies Picture
Figure United States Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Post Herpetic Neuralgia Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Depomed Basic Information, Manufacturing Base and Competitors
Table Depomed Post Herpetic Neuralgia Drugs Type and Applications
Table Depomed Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Post Herpetic Neuralgia Drugs Type and Applications
Table Pfizer Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Post Herpetic Neuralgia Drugs Type and Applications
Table Daiichi Sankyo Post Herpetic Neuralgia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Post Herpetic Neuralgia Drugs Sales by Manufacturer (2017-2018)
Figure Global Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturer in 2017
Figure Global Post Herpetic Neuralgia Drugs Sales Market Share by Manufacturer in 2018
Table Global Post Herpetic Neuralgia Drugs Revenue by Manufacturer (2017-2018)
Figure Global Post Herpetic Neuralgia Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Post Herpetic Neuralgia Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Post Herpetic Neuralgia Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Post Herpetic Neuralgia Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Global Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales by Regions (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales Market Share by Regions (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Revenue by Regions (2014-2019)
Figure Global Post Herpetic Neuralgia Drugs Revenue Market Share by Regions in 2014
Figure Global Post Herpetic Neuralgia Drugs Revenue Market Share by Regions in 2018
Figure North America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Europe Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure South America Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure North America Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table North America Post Herpetic Neuralgia Drugs Sales by Countries (2014-2019)
Table North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2014-2019)
Figure North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2014
Figure North America Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2018
Table North America Post Herpetic Neuralgia Drugs Revenue by Countries (2014-2019)
Table North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2014
Figure North America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2018
Figure United States Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Canada Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Europe Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table Europe Post Herpetic Neuralgia Drugs Sales by Countries (2014-2019)
Table Europe Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2014-2019)
Table Europe Post Herpetic Neuralgia Drugs Revenue by Countries (2014-2019)
Figure Europe Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2017
Figure Europe Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2018
Figure Germany Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure UK Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure France Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Russia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Italy Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Post Herpetic Neuralgia Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Post Herpetic Neuralgia Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Post Herpetic Neuralgia Drugs Revenue Market Share by Countries 2018
Figure China Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Japan Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Korea Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure India Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure South America Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table South America Post Herpetic Neuralgia Drugs Sales by Countries (2014-2019)
Table South America Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2014-2019)
Figure South America Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2018
Table South America Post Herpetic Neuralgia Drugs Revenue by Countries (2014-2019)
Table South America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2018
Figure Brazil Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Post Herpetic Neuralgia Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Post Herpetic Neuralgia Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Post Herpetic Neuralgia Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2014
Figure Middle East and Africa Post Herpetic Neuralgia Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure UAE Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Post Herpetic Neuralgia Drugs Sales and Growth Rate (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales by Type (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales Share by Type (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Revenue by Type (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Revenue Share by Type (2014-2019)
Figure Global Anticonvulsants Sales Growth (2014-2019)
Figure Global Anticonvulsants Price (2014-2019)
Figure Global Antidepressants Sales Growth (2014-2019)
Figure Global Antidepressants Price (2014-2019)
Figure Global Opioids Sales Growth (2014-2019)
Figure Global Opioids Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales by Application (2014-2019)
Table Global Post Herpetic Neuralgia Drugs Sales Share by Application (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Post Herpetic Neuralgia Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Sales Forecast by Regions (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
Figure Europe Sales Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
Figure South America Sales Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Post Herpetic Neuralgia Drugs Market Forecast (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Sales Forecast by Type (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Market Share Forecast by Type (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Sales Forecast by Application (2019-2024)
Table Global Post Herpetic Neuralgia Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のヘルペス後神経痛治療市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antivi…- 世界のヘルペス後神経痛パッチ市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The patch is applied after a PHN patient's skin has been pretreated with a local anesthetic or an oral analgesic. Scope of the Report: The worldwide market for Post Herpetic Neuralgia …
- 世界のめまい薬市場予測（～2024年） Vertigo is a symptom of several different health conditions such as labyrinthitis and meniere's disease. Scope of the Report: The worldwide market for Vertigo Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, …
- 世界のポルフィリン症薬市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, f…
- 世界の粘膜類天疱瘡薬市場予測（～2024年） Mucous membrane pemphigoid is an autoimmune blistering disorder that is characterized by subepithelial bullae. Scope of the Report: The worldwide market for Mucous Membrane Pemphigoid Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from…